Home » Search

Search Results

14026 results for 'articles'

To refine your search through our archives use our Advanced Search

“Encore in Black & White Gala”

Jan. 30
Skyline Club
Jerome Collins, of the a cappella sensation Straight No Chaser, will be
singing Motown hits as musical guest for this dessert-and-entertainment benefit for Encore Vocal Arts. I’ll be serving
as emcee for the event—and trying to land some sweet silent auction deals. To give a listen to Collins, click here.  Details on the event here.

Also this week:

Broadway star Sutton Foster (“Thoroughly Modern Millie,” “Shrek,” “Young Frankenstein) offers
a public presentation Jan. 30 at Ball State’s Sursa Performing Arts Hall. Details here.

The Indianapolis Symphony Orchestra is joined
by the Indianapolis Symphonic Choir, the Butler University Chorale and baritone Hugh Russell for an evening of Dvorak and
Faure, Jan. 29-30 at Hilbert Circle Theatre. Details here.

Groovaloo

Jan. 30
Clowes Hall
High-energy hip-hop dancing is the order of the day for this head-spinning,
arm-crossing, floor-sliding, rubber-limbed company that came to national attention on NBC’s “America’s Best
Dance Crew.” It’s part of the Clowes Presents series, our leading dance importer. Details here.
 

“Touch of Evil”

Jan. 30
Skyline Club
Jerome Collins, of the a cappella sensation Straight No Chaser, will be singing Motown hits as musical guest for this dessert-and-entertainment benefit for Encore Vocal Arts. I’ll be serving as emcee for the event—and trying to land some sweet silent auction deals. To give a listen to Collins, click here. Details on the event here.

“Touch of Evil”

Jan. 29
Tobias Theatre, Indianapolis Museum of Art
Truth be told, I haven’t seen the 1958
Orson Welles film “Touch of Evil” since I was in college. Back then, I wasn’t a fan of movies that called
attention to the direction, and so my voice didn’t join the praise for its miraculous opening tracking shot and other
how-did-they-do-that feats of cinematography.
It could be time for a revisit, though, since one of the film’s
most ardent fans will be introducing it for this one-time-only screening at the IMA. That’s Peter Bogdanovich, who has
created his own share of memorable on-screen moments as a director (“Paper Moon,” “The Last Picture Show,”
and “What’s Up, Doc?”) and actor (“The Sopranos”). Details here.
 

Art & Soul Kickoff

Jan. 30
Indianapolis Artsgarden
A month of concerts and other arts activities in the Artsgarden
gets started with this free program from 1-4 p.m. It includes artist booths and performances by, among others, James Andrews
and New Seasons (give a listen here)
and the Phi Beta Sigma Step Team. Additional Art & Soul performances in February include Asante Children’s Theatre
(Feb. 7), songstress Brenda Williams (Feb. 17), and poet Tasha Jones (Feb. 21). Details here.

“Art from the Heartland”

Jan. 28-April 18
Indianapolis Art Center
The first of what will become a biennial exhibition
features 70 works by 50 artists from Indiana, its neighbor states and, just for good measure, Wisconsin. Local artists include
Amy Brier (creator of the rolling limestone ball pieces at White River Gardens) and Deborah Klein, who works in delicately
cut paper (see samples here). The show was juried by arts advocate Paul Klein, author of the popular Chicago blog ArtLetter.
Details here.

Two companies set to make major local expansions

Express Scripts Inc. on the west side of Indianapolis and Zipp Speed Weaponry in Speedway are scheduled Wednesday afternoon
to announce the
creation of hundreds of new jobs.

Toyota suspending production at two Indiana plants

Toyota is halting production at six North American car-assembly plants—including Indiana facilities in Princeton and
Lafayette—beginning the week of Feb. 1 to fix gas pedals that could stick and cause acceleration without warning.

Senate panel changes gambling, reading bills

The Senate Appropriations Committee voted Tuesday night to remove provisions that would have allowed casinos on Lake Michigan
and the Ohio River to move inland. It also made major changes to legislation that would have required schools to hold back
third-graders if they couldn’t read well.

Company news

The Indiana University School of Medicine in Indianapolis will be one of 12 sites for a clinical trial
of a potentially groundbreaking treatment for autism. New York-based Curemark LLC has developed an ingestible powder designed
to help patients digest protein. The drug is the product of research by Curemark founder Dr. Joan Fallon, who found that many
autistic children lack enzymes to digest protein, meaning their bodies cannot produce the amino acids crucial in brain development.
If it proves effective against autism, the powder, called CA-MT, would be the first treatment to reverse the underlying causes
of autism.

Hopes rose Tuesday that Eli Lilly and Co. and its partner Amylin Pharmaceuticals Inc.
will win approval of their new version of diabetes treatment Byetta. That’s because the U.S. Food and Drug Administration
on Monday approved a Byetta rival, Victoza, developed by Denmark-based Novo Nordisk A/S. Victoza is a once-daily shot, compared
with the twice-daily Byetta. But Indianapolis-based Lilly and San Diego-based Amylin have asked the FDA to approve a once-weekly
version of Byetta, which would be the most convenient for patients. Analysts expect sales of once-weekly Byetta to reach as
high as $2 billion by 2015, which would be split by Lilly and Amylin. Sales of twice-daily Byetta last year were on pace to
reach about $790 million. What’s been holding up Victoza and the once-weekly Byetta have been regulator concerns about
patients developing inflammation of the pancreas while taking the drugs. The FDA required Victoza’s label to warn about
pancreatitis as well as use in patients at risk for a rare thyroid cancer. Those warnings were milder than many analysts had
feared. One analyst expects the FDA to make a decision on once-weekly Byetta by March 5.

Warsaw-based Symmetry
Medical Inc. will manufacture implants, instruments and cases for OrthoPediatrics Corp., another
Warsaw-based company that makes orthopedic implants for children. Symmetry expects to bring in $3 million in revenue from
the deal this year. Symmetry also will receive fees for inventory management, warehousing and supply-chain management services.
The agreement will last for five years.

Lilly looks to autoimmune drugs

Two local researchers show why Eli Lilly and Co. and its peers are interested in developing medicines to treat automimmune
diseases: The costs of treating them are growing twice as fast as the prescription drug market.